Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Canadian Open-Label Study to Evaluate the Safety and Effectiveness of Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriatic Arthritis (PsA) (ACCLAIM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00427362
Recruitment Status : Completed
First Posted : January 29, 2007
Last Update Posted : May 2, 2008
Sponsor:
Information provided by:
Abbott

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2007
  Study Completion Date : No date given